GENFIT, LabCorp sign exclusive agreement to commercialise novel diagnostic test for liver disease
As part of the agreement, LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 20
As part of the agreement, LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4…
29 Sep 20
Quidel is engaged in development of diagnostic solutions that can lead to improved patient outcomes and provide economic…
28 Sep 20
The CDx test kit will use a real-time PCR fluorescent probe, along with specific primers, Taqman probes, and…
28 Sep 20
The study will assess the patients with Covid-related symptoms, which meet the CDC guidelines as assessed by a…
28 Sep 20
AID Genomics will also support Todos in validating and commercialising its proprietary tests in Israel
25 Sep 20
SMG has already tested the market with age-management clinics in France, Italy and Greece, the on-going development of…
25 Sep 20
Under the EUA, the ORAcollect•RNA (OR-100) device can be used to collect saliva samples from individuals suspected of…
25 Sep 20
The expanded NxTAG RPP combines Luminex's original NxTAG RPP, an FDA-cleared in vitro diagnostic for syndromic respiratory infection…
25 Sep 20
Babson’s advanced diagnostic technology was incubated at Siemens Healthineers and developed in partnership with Becton Dickinson
24 Sep 20
The RNA-based diagnostic test is developed by the company in partnership with SUNY Upstate Medical University